244 related articles for article (PubMed ID: 19360860)
21. Safety and efficacy of bivalirudin for percutaneous coronary intervention with rotational atherectomy.
Delhaye C; Wakabayashi K; Maluenda G; Ben-Dor I; Torguson R; Xue Z; Suddath WO; Satler LF; Pichard AD; Kent KM; Lindsay J; Waksman R
J Interv Cardiol; 2010 Jun; 23(3):223-9. PubMed ID: 20636842
[TBL] [Abstract][Full Text] [Related]
22. Impact of anticoagulation strategy with bivalirudin or heparin on nonaccess site bleeding in percutaneous coronary interventions: A meta-analysis of randomized trials.
Verdoia M; Barbieri L; Parodi G; Bellandi B; Schaffer A; Suryapranata H; De Luca G
Catheter Cardiovasc Interv; 2017 Oct; 90(4):553-565. PubMed ID: 28471057
[TBL] [Abstract][Full Text] [Related]
23. Comparison of patient outcomes with bivalirudin versus unfractionated heparin in percutaneous coronary intervention.
Watson K; Seybert AL; Saul MI; Lee JS; Kane-Gill SL
Pharmacotherapy; 2007 May; 27(5):647-56. PubMed ID: 17461699
[TBL] [Abstract][Full Text] [Related]
24. Bivalirudin during primary PCI in acute myocardial infarction.
Stone GW; Witzenbichler B; Guagliumi G; Peruga JZ; Brodie BR; Dudek D; Kornowski R; Hartmann F; Gersh BJ; Pocock SJ; Dangas G; Wong SC; Kirtane AJ; Parise H; Mehran R;
N Engl J Med; 2008 May; 358(21):2218-30. PubMed ID: 18499566
[TBL] [Abstract][Full Text] [Related]
25. Association Of Bleeding Avoidance Strategies with age-related bleeding and In-hospital mortality in patients undergoing percutaneous coronary Interventions.
Khambatta S; Othman H; Seth M; Lalonde T; Rosman HS; Gurm HS; Mehta RH;
Cardiovasc Revasc Med; 2016 Jun; 17(4):233-40. PubMed ID: 26994504
[TBL] [Abstract][Full Text] [Related]
26. Clinical Outcomes of Bivalirudin Versus Heparin in Elderly Patients Undergoing Percutaneous Coronary Intervention: a Systematic Review and Meta-analysis of Randomized Controlled Trials.
Meng S; Xu J; Guo L; Huang R
Cardiovasc Drugs Ther; 2020 Feb; 34(1):101-111. PubMed ID: 32100149
[TBL] [Abstract][Full Text] [Related]
27. Effectiveness and safety of bivalirudin in elderly patients with coronary artery disease undergoing percutaneous coronary intervention: A real-world study.
Li J; Liu X; Ma S; Na K; Qi Z; Xu Y; Qiu M; Han Y; Li Y
Catheter Cardiovasc Interv; 2022 May; 99 Suppl 1():1448-1455. PubMed ID: 35077603
[TBL] [Abstract][Full Text] [Related]
28. Novel approaches for preventing or limiting events (Naples) III trial: randomized comparison of bivalirudin versus unfractionated heparin in patients at increased risk of bleeding undergoing transfemoral elective coronary stenting.
Briguori C; Visconti G; Focaccio A; Donahue M; Golia B; Selvetella L; Ricciardelli B
JACC Cardiovasc Interv; 2015 Mar; 8(3):414-423. PubMed ID: 25703878
[TBL] [Abstract][Full Text] [Related]
29. Temporal trends, safety, and efficacy of bivalirudin in elective percutaneous coronary intervention: insights from the Blue Cross Blue Shield of Michigan Cardiovascular Consortium.
Gurm HS; Smith DE; Chetcuti SJ; Share D; Khanal S; Riba A; Carter AJ; Lalonde T; Kline-Rogers E; O'Donnell M; O'Neill W; Safian R; Moscucci M;
J Interv Cardiol; 2007 Jun; 20(3):197-203. PubMed ID: 17524111
[TBL] [Abstract][Full Text] [Related]
30. Heparin versus bivalirudin for non-primary percutaneous coronary intervention: A post-Hoc analysis of the CPORT-E trial.
Czarny MJ; Hwang CW; Naiman DQ; Lemmon CC; Hasan RK; Wang T; Aversano T
Catheter Cardiovasc Interv; 2017 Sep; 90(3):366-377. PubMed ID: 28160375
[TBL] [Abstract][Full Text] [Related]
31. Bivalirudin versus heparin, without glycoprotein inhibition, in percutaneous coronary intervention: A comparison of ischemic and hemorrhagic outcomes over 10years.
Chaudry HI; Curran TB; Andrus BW; Conley SM; DeVries JT
Cardiovasc Revasc Med; 2018; 19(3 Pt B):338-342. PubMed ID: 29055661
[TBL] [Abstract][Full Text] [Related]
32. Gender-based outcomes of bivalirudin versus heparin in patients undergoing percutaneous coronary interventions: Meta-analysis of randomized controlled trials.
Mina GS; Firouzbakht T; Modi K; Dominic P
Catheter Cardiovasc Interv; 2017 Nov; 90(5):735-742. PubMed ID: 28339139
[TBL] [Abstract][Full Text] [Related]
33. Bleeding after percutaneous coronary intervention with Bivalirudin or unfractionated Heparin and one-year mortality.
Ndrepepa G; Schulz S; Keta D; Mehilli J; Birkmeier A; Massberg S; Laugwitz KL; Neumann FJ; Seyfarth M; Berger PB; Schömig A; Kastrati A
Am J Cardiol; 2010 Jan; 105(2):163-7. PubMed ID: 20102912
[TBL] [Abstract][Full Text] [Related]
34. Anticoagulant Use Among Patients With End-Stage Renal Disease Undergoing Percutaneous Coronary Intervention: An Analysis From the National Cardiovascular Data Registry.
Washam JB; Kaltenbach LA; Wojdyla DM; Patel MR; Klein AJ; Abbott JD; Rao SV
Circ Cardiovasc Interv; 2018 Feb; 11(2):e005628. PubMed ID: 29432119
[TBL] [Abstract][Full Text] [Related]
35. Bivalirudin versus unfractionated heparin during percutaneous coronary intervention.
Kastrati A; Neumann FJ; Mehilli J; Byrne RA; Iijima R; Büttner HJ; Khattab AA; Schulz S; Blankenship JC; Pache J; Minners J; Seyfarth M; Graf I; Skelding KA; Dirschinger J; Richardt G; Berger PB; Schömig A;
N Engl J Med; 2008 Aug; 359(7):688-96. PubMed ID: 18703471
[TBL] [Abstract][Full Text] [Related]
36. Hemorrhagic and ischemic outcomes after bivalirudin versus unfractionated heparin during carotid artery stenting: a propensity score analysis from the NCDR.
Wayangankar SA; Abu-Fadel MS; Aronow HD; Kennedy KF; Gupta R; Yeh RW; Gray WA; Rosenfield K; Hennebry TA
Circ Cardiovasc Interv; 2013 Apr; 6(2):131-8. PubMed ID: 23532554
[TBL] [Abstract][Full Text] [Related]
37. Frequency and outcomes of provisional glycoprotein IIb/IIIa blockade in patients receiving bivalirudin during percutaneous coronary intervention.
Feldman DN; Wong SC; Bergman G; Minutello RM
J Invasive Cardiol; 2009 Jun; 21(6):258-63. PubMed ID: 19494400
[TBL] [Abstract][Full Text] [Related]
38. Efficacy and safety of bivalirudin during percutaneous coronary intervention in high-bleeding-risk elderly patients with chronic total occlusion: A prospective randomized controlled trial.
Wang Y; Zhao HW; Wang CF; Fan CY; Zhang XJ; Zhu Y; Luo DF; Yu GN; Hou AJ; Luan B
Catheter Cardiovasc Interv; 2019 Feb; 93(S1):825-831. PubMed ID: 30724035
[TBL] [Abstract][Full Text] [Related]
39. Benefit of bivalirudin versus heparin after transradial and transfemoral percutaneous coronary intervention.
MacHaalany J; Abdelaal E; Bataille Y; Plourde G; Duranleau-Gagnon P; Larose É; Déry JP; Barbeau G; Rinfret S; Rodés-Cabau J; De Larochellière R; Roy L; Costerousse O; Bertrand OF
Am J Cardiol; 2012 Dec; 110(12):1742-8. PubMed ID: 22980964
[TBL] [Abstract][Full Text] [Related]
40. Body mass index and bleeding complications after percutaneous coronary intervention: does bivalirudin make a difference?
Delhaye C; Wakabayashi K; Maluenda G; Belle L; Ben-Dor I; Gonzalez MA; Gaglia MA; Torguson R; Xue Z; Suddath WO; Satler LF; Kent KM; Lindsay J; Pichard AD; Waksman R
Am Heart J; 2010 Jun; 159(6):1139-46. PubMed ID: 20569731
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
